Table 2 Hazard ratios of lipid measures for predicting first cardiovascular disease events among participants without prevalent CVD (n = 5054); Tehran Lipid and Glucose Study (TLGS) (2001–2012)^a

Men

 TC

1.10

1.34(1.22-1.47)

<0.001

1.3(1.18-1.43)

<0.001

 LDL-C

0.93

1.37(1.25-1.51)

<0.001

1.33(1.2-1.46)

<0.001

 HDL-C

0.25

0.88(0.79-0.98)

0.021

0.94(0.84-1.04)

0.24

 Non-HDL-C

1.11

1.37(1.25-1.5)

<0.001

1.32(1.20-1.45)

<0.001

 ln-TGs

0.57

1.20(1.09-1.3)

<0.001

1.1(1.0-1.21)

0.05

 TC/HDL-C

1.85

1.10(1.13-1.28)

<0.001

1.17(1.09-1.25)

<0.001

 ln-TGs/HDL-C

0.7

1.2(1.1-1.31)

<0.001

1.1(1.0-1.21)

0.056

Women

 TC

1.24

1.30(1.18-1.43)

<0.001

1.21(1.1-1.34)

<0.001

 LDL-C

1.05

1.30(1.19-1.43)

<0.001

1.22(1.11-1.35)

<0.001

 HDL-C

0.29

0.87(0.78-0.98)

0.02

0.91(0.82-1.02)

0.11

 Non-HDL-C

1.23

1.32(1.20-1.45)

<0.001

1.23(1.12-1.36)

<0.001

 ln-TGs

0.51

1.42(1.27-1.58)

<0.001

1.24(1.1-1.4)

<0.001

 TC/HDL-C

1.69

1.33(1.21-1.46)

<0.001

1.26(1.13-1.4)

<0.001

 ln-TGs/HDL-C

0.65

1.38(1.23-1.54)

<0.001

1.22(1.09-1.38)

0.001

Total

 TC

1.21

1.33(1.24-1.42)

<0.001

1.26(1.18-1.35)

<0.001

 LDL-C

1.01

1.34(1.26-1.43)

<0.001

1.27(1.19-1.36)

<0.001

 HDL-C

0.28

0.88(0.81-0.95)

0.001

0.93(0.86-1.007)

0.07

 Non-HDL-C

1.19

1.35(1.26-1.44)

<0.001

1.22(1.14-1.30)

<0.001

 ln-TGs

0.53

1.28(1.20-1.37)

<0.001

1.15(1.07-1.24)

<0.001

 TC/HDL-C

1.78

1.24(1.18-1.30)

<0.001

1.18(1.12-1.25)

<0.001

 ln-TGs/HDL-C

0.67

1.27(1.18-1.36)

<0.001

1.14(1.06-1.23)

<0.001